Use of transgenic and knockout mouse models to assess solute carrier transporter function

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 4, 2011, Pages 612-616

  Degorter, M K ^a   Kim, R B ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; MULTIDRUG AND TOXIN EXTRUSION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 1A; ORGANIC ANION TRANSPORTER 1B; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 3; SOLUTE CARRIER; UNCLASSIFIED DRUG;

ARTICLE; DRUG DISPOSITION; DRUG RESPONSE; DRUG TRANSPORT; IN VIVO STUDY; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSGENIC MOUSE;

ANIMALS; BIOLOGICAL TRANSPORT; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, ANIMAL; ORGANIC ANION TRANSPORTERS; ORGANIC CATION TRANSPORT PROTEINS; TISSUE DISTRIBUTION; XENOBIOTICS;

EID: 79952991292     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.2     Document Type: Article

References (27)

1. Tirona, R.G. & Kim, R.B. Organic anion-transporting polypeptides. In Drug Transporters (eds You, G. & Morris, M.E.) 75-104 (Wiley, Hoboken, NJ, 2007).
2. Fahrmayr, C., Fromm, M.F. & König, J. Hepatic OaTp and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects. Drug Metab. Rev. 42, 380-401 (2010).
3. Zaher, H. et al. Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin. Mol. Pharmacol. 74, 320-329 (2008).
4. Chen, C. et al. Utility of a novel Oatp1b2 knockout mouse model for evaluating the role of Oatp1b2 in the hepatic uptake of model compounds. Drug Metab. Dispos. 36, 1840-1845 (2008).
5. Lu, H. et al. Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR. Toxicol. Sci. 103, 35-45 (2008). (Pubitemid 351524475)
6. Van de Steeg, E. et al. Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1). Drug Metab. Dispos. 37, 277-281 (2009).
7. Van de Steeg, E. et al. Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, Bile acids, And drugs. J. Clin. Invest. 120, 2942-2952 (2010).
8. Van, T.T. et al. The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice. Cancer Chemother. Pharmacol. (2010); e-pub ahead of print 16 November 2010.
9. Meyer Zu Schwabedissen, H.E., Bottcher, K., Chaudhry, A., Kroemer, H.K., Schuetz, E.G. & Kim, R.B. Liver X receptor alpha and farnesoid X receptor are major transcriptional regulators of OaTp1B1. Hepatology 52, 1797-1807 (2010).
10. VanWert, A.L., Gionfriddo, M.R. & Sweet, D.H. Organic anion transporters: discovery, Pharmacology, Regulation and roles in pathophysiology. Biopharm. Drug Dispos. 31, 1-71 (2010).
11. Sweet, D.H., Miller, D.S., Pritchard, J.B., Fujiwara, Y., Beier, D.R. & Nigam, S.K. Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J. Biol. Chem. 277, 26934-26943 (2002). (Pubitemid 34951703)
12. Eraly, S.A. et al. Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OaT1 knock-out mice. J. Biol. Chem. 281, 5072-5083 (2006). (Pubitemid 43847773)
13. Vanwert, A.L., Bailey, R.M. & Sweet, D.H. Organic anion transporter 3 (Oat3/ Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G. Am. J. Physiol. Renal Physiol. 293, F1332-F1341 (2007). (Pubitemid 47583969)
14. Vanwert, A.L., Srimaroeng, C. & Sweet, D.H. Organic anion transporter 3 (oat3/ slc22a8) interacts with carboxyfluoroquinolones, And deletion increases systemic exposure to ciprofloxacin. Mol. Pharmacol. 74, 122-131 (2008). (Pubitemid 351872164)
15. VanWert, A.L. & Sweet, D.H. Impaired clearance of methotrexate in organic anion transporter 3 (Slc22a8) knockout mice: a gender specific impact of reduced folates. Pharm. Res. 25, 453-462 (2008). (Pubitemid 351257979)
16. Vallon, V., Rieg, T., Ahn, S.Y., Wu, W., Eraly, S.A. & Nigam, S.K. Overlapping in vitro and in vivo specificities of the organic anion transporters OaT1 and OaT3 for loop and thiazide diuretics. Am. J. Physiol. Renal Physiol. 294, F867-F873 (2008).
17. Ose, A. et al. Limited brain distribution of [3R,4R,5S]-4-acetamido-5- amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), A pharmacologically active form of oseltamivir, By active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/abcc4). Drug Metab. Dispos. 37, 315-321 (2009).
18. Jonker, J.W. et al. Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene. Mol. Cell. Biol. 21, 5471-5477 (2001). (Pubitemid 32702451)
19. Jonker, J.W., Wagenaar, E., Van Eijl, S. & Schinkel, A.H. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations. Mol. Cell. Biol. 23, 7902-7908 (2003). (Pubitemid 37271485)
20. Wang, D.S., Jonker, J.W., Kato, Y., Kusuhara, H., Schinkel, A.H. & Sugiyama, Y. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. J. Pharmacol. Exp. Ther. 302, 510-515 (2002). (Pubitemid 34787213)
21. Wang, D.S., Kusuhara, H., Kato, Y., Jonker, J.W., Schinkel, A.H. & Sugiyama, Y. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. Mol. Pharmacol. 63, 844-848 (2003). (Pubitemid 36368991)
22. Shu, Y. et al. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J. Clin. Invest. 117, 1422-1431 (2007). (Pubitemid 46718430)
23. Filipski, K.K., Mathijssen, R.H., Mikkelsen, T.S., Schinkel, A.H. & Sparreboom, A. Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity. Clin. Pharmacol. Ther. 86, 396-402 (2009).
24. Ciarimboli, G. et al. Organic cation transporter 2 mediates cisplatin-induced oto-and nephrotoxicity and is a target for protective interventions. Am. J. Pathol. 176, 1169-1180 (2010).
25. Tsuda, M., Terada, T., Mizuno, T., Katsura, T., Shimakura, J. & Inui, K. Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin. Mol. Pharmacol. 75, 1280-1286 (2009).
26. Nakamura, T., Yonezawa, A., Hashimoto, S., Katsura, T. & Inui, K. Disruption of multidrug and toxin extrusion MaTE1 potentiates cisplatin-induced nephrotoxicity. Biochem. Pharmacol. 80, 1762-1767 (2010).
27. Watanabe, S., Tsuda, M., Terada, T., Katsura, T. & Inui, K. Reduced renal clearance of a zwitterionic substrate cephalexin in MaTE1-deficient mice. J. Pharmacol. Exp. Ther. 334, 651-656 (2010).